SPATA20

There is 1 paper on SPATA20 in aging research: 1 observational study in people. The newest story, Oct 23, 2026: “Two blood proteins linked to small-vessel stroke risk”.

Gene

1 paper studies it1 finding

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 1 papers on SPATA20

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“For SVD, higher SPATA20 raised risk (OR 1.47, 95% CI 1.24-1.73, p = 5.3 × 10−6)”
Proteome-Wide Mendelian Randomization Identifies Therapeutic Targets for Ischemic StrokeTranslational stroke research2026doi:10.1007/s12975-026-01509-7
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Department of Finance of Jilin Province
  • Humans1

Associations

1

Small vessel disease

upin humans1OR 1.47

1 study
  1. SPATA20 is linked with a higher risk of small vessel disease in humans (Genetically predicted circulating protein level) (OR 1.47, 95% CI 1.24-1.73).

    “For SVD, higher SPATA20 raised risk (OR 1.47, 95% CI 1.24-1.73, p = 5.3 × 10−6)”

    HumansGenetically predicted circulating protein level

    Two blood proteins linked to small-vessel stroke risk

    Translational stroke research

More on Small vessel disease

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months
Translational Stroke Research

Two blood proteins linked to small-vessel stroke risk

Higher levels of blood proteins SPATA20 and KDELC2 were linked to higher and lower small-vessel stroke odds, respectively (odds ratios 1.47 and 0.82).Higher levels of blood proteins SPATA20 and KDELC2 were linked to higher and lower small-vessel stroke odds, respectively (odds ratios 1.47 and 0.82).

Mendelian randomizationMechanisms